Table 2.
Top five most significantly (p < 0.05) overrepresented gene ontology (GO) terms and Kyoto encyclopedia of genes and genomes (KEGG) pathways represented by either hypo- or hypermethylated differentially methylated region (DMR)-associated genes implicated by Stress treatment compared to control (p < 0.01).
Hypomethylated | p-value | Hypermethylated | p-value |
---|---|---|---|
Term | Term | ||
Molecular function | |||
SUMO-specific protease activity | 0.005 | voltage-gated potassium channel activity in ventricular cardiac muscle cell action potential repolarization | 4.96E-04 |
protein-arginine omega-N asymmetric methyltransferase activity | 0.007 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization | 0.002 |
nonmembrane spanning protein tyrosine kinase activity | 0.009 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 0.004 |
histone-arginine N-methyltransferase activity | 0.010 | cytokine activity | 0.006 |
arginine N-methyltransferase activity | 0.014 | peptidyl-proline 4-dioxygenase activity | 0.006 |
Biological process | |||
histone methylation | 0.003 | positive regulation of protein secretion | 3.88E-04 |
smooth muscle contraction | 0.005 | regulation of macrophage cytokine production | 0.001 |
apoptotic nuclear changes | 0.007 | ventricular cardiac muscle cell membrane repolarization | 0.001 |
regulation of microtubule cytoskeleton organization | 0.007 | positive regulation of cytokine secretion | 0.001 |
neuron projection extension in neuron projection guidance | 0.007 | cardiac muscle cell membrane repolarization | 0.001 |
Cellular component | |||
multivesicular body membrane | 0.005 | multivesicular body | 0.025 |
T cell receptor complex | 0.009 | T cell receptor complex | 0.045 |
actin cytoskeleton | 0.017 | platelet alpha granule | 0.045 |
multivesicular body | 0.021 | ||
cytoplasmic stress granule | 0.024 | ||
KEGG pathway | |||
Chemokine signaling pathway | 0.020 | Cytokine-cytokine receptor interaction | 1.34E-06 |
Neuroactive ligand-receptor interaction | 0.008 | ||
Antigen processing and presentation | 0.013 | ||
TGF-beta signaling pathway | 0.013 | ||
Hematopoietic cell lineage | 0.015 |